Trial intelligence / Profile preview

Sequential Daivobet and Daivonex in Psoriasis

NCT00437619Phase 4Completed

Sponsor
Roche
Start
Feb 2007
Primary completion
Aug 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of calcipotriol + betamethasone, calcipotriol in Psoriasis vulgaris (PV), sponsored by Roche. Started Feb 2007; status: completed.

02

Drugs

calcipotriol + betamethasonecalcipotriol
03

Conditions

Psoriasis vulgaris (PV)

Beyond the preview

Go deeper on NCT00437619.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00437619.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call